"Medical Oncology" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A subspecialty of internal medicine concerned with the study of neoplasms.
Descriptor ID |
D008495
|
MeSH Number(s) |
H02.403.429.515
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Medical Oncology".
Below are MeSH descriptors whose meaning is more specific than "Medical Oncology".
This graph shows the total number of publications written about "Medical Oncology" by people in this website by year, and whether "Medical Oncology" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 1 | 0 | 1 |
1995 | 3 | 1 | 4 |
1996 | 1 | 0 | 1 |
1997 | 4 | 2 | 6 |
1998 | 1 | 1 | 2 |
1999 | 3 | 3 | 6 |
2000 | 2 | 5 | 7 |
2001 | 6 | 2 | 8 |
2002 | 1 | 0 | 1 |
2003 | 6 | 4 | 10 |
2004 | 7 | 4 | 11 |
2005 | 16 | 10 | 26 |
2006 | 19 | 8 | 27 |
2007 | 16 | 15 | 31 |
2008 | 18 | 12 | 30 |
2009 | 18 | 15 | 33 |
2010 | 16 | 14 | 30 |
2011 | 26 | 18 | 44 |
2012 | 21 | 9 | 30 |
2013 | 26 | 10 | 36 |
2014 | 37 | 13 | 50 |
2015 | 40 | 8 | 48 |
2016 | 27 | 16 | 43 |
2017 | 39 | 23 | 62 |
2018 | 36 | 30 | 66 |
2019 | 36 | 33 | 69 |
2020 | 33 | 33 | 66 |
2021 | 31 | 32 | 63 |
2022 | 9 | 34 | 43 |
2023 | 11 | 53 | 64 |
2024 | 2 | 10 | 12 |
To return to the timeline,
click here.
Below are the most recent publications written about "Medical Oncology" by people in Profiles.
-
The roles of ferroptosis in cancer: Tumor suppression, tumor microenvironment, and therapeutic interventions. Cancer Cell. 2024 Apr 08; 42(4):513-534.
-
A Vision for Democratizing Next-Generation Oncology Clinical Trials. Cancer Discov. 2024 Apr 04; 14(4):579-584.
-
Cancer biomarkers: Emerging trends and clinical implications for personalized treatment. Cell. 2024 Mar 28; 187(7):1617-1635.
-
Differential Treatment Effects of Subgroup Analyses in Phase 3 Oncology Trials From 2004 to 2020. JAMA Netw Open. 2024 Mar 04; 7(3):e243379.
-
Tumor-agnostic baskets to N-of-1 platform trials and real-world data: Transforming precision oncology clinical trial design. Cancer Treat Rev. 2024 Apr; 125:102703.
-
Integrating Yoga in Oncologic Care: Answering the Call to Develop Best Practices. J Integr Complement Med. 2024 Mar; 30(3):209-215.
-
Child Health and the Pediatric Hematology-Oncology Workforce: 2020-2040. Pediatrics. 2024 Feb 01; 153(Suppl 2).
-
ESGO-ESMO-ESP consensus conference recommendations on ovarian cancer: pathology and molecular biology and early, advanced and recurrent disease. Ann Oncol. 2024 Mar; 35(3):248-266.
-
Translational and oncologic significance of tertiary lymphoid structures in pancreatic adenocarcinoma. Front Immunol. 2024; 15:1324093.
-
Introduction to the JVIR Special Issue Focusing on Interventional Radiology and Immuno-oncology. J Vasc Interv Radiol. 2024 Feb; 35(2):163.